Xueying Li

6PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 12, 2023
Dasatinib plus prednisone as induction and consolidation for adults with Ph-positive acute lymphoblastic leukaemia: A single-arm, multicentre, phase 2 trial.

Mixue Xie, Ying Lu, Guifang Ouyang

|Mar 25, 2021
Minimal residual disease level determined by flow cytometry provides reliable risk stratification in adults with T-cell acute lymphoblastic leukaemia.

Huanping Wang, Yile Zhou, Xin Huang

|Dec 11, 2020
CDKN2A deletions are associated with poor outcomes in 101 adults with T-cell acute lymphoblastic leukemia.

Huan-Ping Wang, Yi-Le Zhou, Xin Huang

|Nov 18, 2020
Prognostic significance of a normal karyotype in adult patients with BCR-ABL1-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era.

Ting Shi, Huanping Wang, Mixue Xie

Pageof 1

Frequent Collaborators

4 joint publications

Jie Jin

4 joint publications

Hongyan Tong

3 joint publications

Xiujin Ye

3 joint publications

Huanping Wang